Emerging Infectious Diseases (Dec 2021)

SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021

  • Jackie Kleynhans,
  • Stefano Tempia,
  • Nicole Wolter,
  • Anne von Gottberg,
  • Jinal N. Bhiman,
  • Amelia Buys,
  • Jocelyn Moyes,
  • Meredith L. McMorrow,
  • Kathleen Kahn,
  • F. Xavier Gómez-Olivé,
  • Stephen Tollman,
  • Neil A. Martinson,
  • Floidy Wafawanaka,
  • Limakatso Lebina,
  • Jacques du Toit,
  • Waasila Jassat,
  • Mzimasi Neti,
  • Marieke Brauer,
  • Cheryl Cohen

DOI
https://doi.org/10.3201/eid2712.211465
Journal volume & issue
Vol. 27, no. 12
pp. 3020 – 3029

Abstract

Read online

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be underestimated because of limited access to testing. We measured SARS-CoV-2 seroprevalence in South Africa every 2 months during July 2020–March 2021 in randomly selected household cohorts in 2 communities. We compared seroprevalence to reported laboratory-confirmed infections, hospitalizations, and deaths to calculate infection–case, infection–hospitalization, and infection–fatality ratios in 2 waves of infection. Post–second wave seroprevalence ranged from 18% in the rural community children <5 years of age, to 59% in urban community adults 35–59 years of age. The second wave saw a shift in age distribution of case-patients in the urban community (from persons 35–59 years of age to persons at the extremes of age), higher attack rates in the rural community, and a higher infection–fatality ratio in the urban community. Approximately 95% of SARS-CoV-2 infections were not reported to national surveillance.

Keywords